Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance.

The American journal of tropical medicine and hygiene - 1 Nov 1996

Plowe C V, Djimde A, Wellems T E, Diop S, Kouriba B, Doumbo O K

Abstract excerpt

Pyrimethamine-sulfadoxine (PS, Fansidar; Hoffman-LaRoche, Basel, Switzerland) is now the first-line antimalarial therapy in parts of Africa with high rates of chloroquine-resistant Plasmodium falciparum. With PS resistance increasing and no suitably inexpensive and effective third antimalarial drug available, strategies for delaying the spread of PS resistance in Africa are needed. Community PS usage was measured...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Microbial

Share to Malaria, Falciparum

Share to Mutation

Share to Plasmodium falciparum

Share to Polymerase Chain Reaction

Share to Prevalence

Source

Identifiers

PMID: 8940973
DOI: 10.4269/ajtmh.1996.55.467

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance.PMID 8940973Read ↗

Genetic profiling of sulfadoxine-pyrimethamine resistance markers in Indian Plasmodium falciparum field isolates.Semantic proximity Read ↗

Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa.Semantic proximity Read ↗

Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi.Semantic proximity Read ↗

Efficacy, Safety, and Selection of Molecular Markers of Drug Resistance by Two ACTs in MaliSemantic proximity Read ↗

Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites.Semantic proximity Read ↗

Genetic surveillance for monitoring the impact of drug use on Plasmodium falciparum populationsSemantic proximity Read ↗

Molecular markers in epidemiological monitoring of the spread of resistance to antimalarials: a review.Semantic proximity Read ↗

Source of drug resistant Plasmodium falciparum in a potential malaria elimination site in Saudi Arabia.Semantic proximity Read ↗

Monitoring antimalarial drug resistance: making the most of the tools at hand.Semantic proximity Read ↗

A clinical and molecular study of artesunate + sulphadoxine-pyrimethamine in three districts of central and eastern IndiaSemantic proximity Read ↗

Monitoring the efficacy of antimalarial medicines in India via sentinel sites: Outcomes and risk factors for treatment failure.Semantic proximity Read ↗

Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.